Avalo Therapeutics CFO Christopher Ryan Sullivan disposes of common shares worth $1.44 million
AVTX•CFO share sale and option exercise
- Avalo Therapeutics CFO Christopher Ryan Sullivan exercised stock options on Aug. 17-18 at USD 9.88.
- He sold 72,725 common shares at prices near USD 19.85 to USD 20.05.
- Directly held common shares fell to 39,900.
